Gyeonggi, South Korea

Hung-Bok Park

This inventor holds 1 USPTO granted patent. Top assignee: Samyang Genex Co.. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hung-Bok Park. Retrieved from https://idiyas.com/inventor/hung-bok-park

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Hung-Bok Park

Introduction

Hung-Bok Park is a notable inventor based in Kyonggi-Do, South Korea. He has made significant contributions to the field of biotechnology, particularly in the purification of valuable compounds from natural sources. His work has implications for the pharmaceutical industry, especially in the production of cancer treatments.

Latest Patents

Hung-Bok Park holds a patent for a "Method for purifying taxol from taxus biomass." This innovative method enhances the efficiency of extracting taxol, a crucial compound used in cancer therapy, from the biomass of the Taxus plant. His patent demonstrates his commitment to advancing biotechnological processes.

Career Highlights

Park is currently employed at Samyang Genex Co., where he continues to develop and refine biotechnological methods. His work at the company has positioned him as a key player in the field, contributing to advancements that benefit both the industry and patients in need of effective treatments.

Collaborations

Hung-Bok Park has collaborated with notable colleagues, including Seung-Suh Hong and Bong-Kyu Song. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas, further enhancing the impact of their work.

Conclusion

Hung-Bok Park's contributions to biotechnology, particularly through his patent for purifying taxol, highlight his role as an influential inventor in the field. His ongoing work at Samyang Genex Co. and collaborations with esteemed colleagues continue to drive advancements in cancer treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…